Implementing oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in sub-Saharan Africa: a phase 3b, open-label, hybrid type 2 implementation and effectiveness trial (MOBILE MEN).

Kusemererwa S, Nayiga B, Lebina L, Bekker LG, Philips A, Matharu LB, Govindasamy D, Meyer-Rath G, Kimbugwe G, Ruzagira E, Shahmanesh M, Seeley J, Webb EL, Fox J

Open source

DOI
10.1186/s13063-025-09138-5
Published
2025 Nov 10
Container
Trials
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-025-09138-5,
  title = {Implementing oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in sub-Saharan Africa: a phase 3b, open-label, hybrid type 2 implementation and effectiveness trial (MOBILE MEN).},
  author = {Kusemererwa S and Nayiga B and Lebina L and Bekker LG and Philips A and Matharu LB and Govindasamy D and Meyer-Rath G and Kimbugwe G and Ruzagira E and Shahmanesh M and Seeley J and Webb EL and Fox J},
  year = {2025},
  journal = {Trials},
  doi = {10.1186/s13063-025-09138-5},
  url = {https://doi.org/10.1186/s13063-025-09138-5}
}

RIS

TY  - JOUR
TI  - Implementing oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in sub-Saharan Africa: a phase 3b, open-label, hybrid type 2 implementation and effectiveness trial (MOBILE MEN).
AU  - Kusemererwa S
AU  - Nayiga B
AU  - Lebina L
AU  - Bekker LG
AU  - Philips A
AU  - Matharu LB
AU  - Govindasamy D
AU  - Meyer-Rath G
AU  - Kimbugwe G
AU  - Ruzagira E
AU  - Shahmanesh M
AU  - Seeley J
AU  - Webb EL
AU  - Fox J
PY  - 2025
JO  - Trials
DO  - 10.1186/s13063-025-09138-5
UR  - https://doi.org/10.1186/s13063-025-09138-5
ER  - 

APA

S, K., B, N., L, L., LG, B., A, P., LB, M., D, G., G, M., G, K., E, R., M, S., J, S., EL, W., & J, F. (2025). Implementing oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in sub-Saharan Africa: a phase 3b, open-label, hybrid type 2 implementation and effectiveness trial (MOBILE MEN).. Trials. https://doi.org/10.1186/s13063-025-09138-5

Source records